Identification of Na+,K+-ATPase inhibitors of volume-expanded hog plasma.
Na+,K+-adenosine triphosphatase (ATPase) inhibitors possessing inhibitory activities against the specific binding of ouabain to Na+,K+-ATPase and 86Rb uptake into hog erythrocytes have been purified from the plasma of hog acutely infused with saline. The purifications were performed by a combination of Amberlite XAD-2 adsorption chromatography and several steps of high performance liquid chromatography using four different types of columns. Inhibitors purified to homogeneity were identified as linoleic and oleic acids, gamma-stearoyllysophosphatidylcholine, gamma-arachidoyllysophosphatidylcholine, gamma-linoleoyllysophosphatidylcholine, and gamma-oleoyllysophosphatidylcholine. Small amounts of beta-arachidoyllysophosphatidylcholine, gamma-docosapentaenoyllysophosphatidylcholine, gamma-eicosatrienoyllysophosphatidylcholine, and gamma-palmitoyllysophosphatidylcholine were also detected by both fast atom bombardment mass and proton nuclear magnetic resonance spectrometric studies. Only gamma-acyllysophosphatidylcholines showed inhibitory activities on Na+,K+-ATPase and ouabain-binding activities. These lysophosphatidylcholines and unsaturated free fatty acids were effective at 100 microM levels in attaining 50% inhibition of the enzyme activity. The ouabain-displacing activity in plasma caused by these compounds increased with time during saline infusion. The maximal plasma levels of these components were approximately 10 times higher than that in the preinfusion plasma sample.
Inagami
T
T
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
Tamura
M
M
D000818:Animals; D001667:Binding, Competitive; D002851:Chromatography, High Pressure Liquid; D002852:Chromatography, Ion Exchange; D005227:Fatty Acids / Q000302:isolation & purification / Q000494:pharmacology; D008244:Lysophosphatidylcholines / Q000302:isolation & purification / Q000494:pharmacology; D010042:Ouabain / Q000378:metabolism / Q000494:pharmacology; D010455:Peptides / Q000302:isolation & purification* / Q000494:pharmacology; D010952:Plasma Substitutes / Q000494:pharmacology; D010953:Plasma Volume; D012413:Rubidium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*; D013552:Swine / Q000097:blood
D005227:Fatty Acids; D008244:Lysophosphatidylcholines; D010455:Peptides; D010952:Plasma Substitutes; C029311:serum sodium transport inhibitor; D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase; D012413:Rubidium